九強生物(300406.SZ)獲得2項專利證書
格隆匯12月9日丨九強生物(300406.SZ)公佈,公司於近期收到中華人民共和國國家知識產權局頒發的2項專利證書,涉一種肌鈣蛋白I的膠乳增強免疫比濁檢測試劑盒;一種肌酸激酶同工酶檢測試劑盒。
1.該申請涉及一種肌鈣蛋白I的膠乳增強免疫比濁檢測試劑盒。具體而言,試劑盒包含第一試劑和第二試劑;第一試劑包含緩衝液、阻斷劑、表面活性劑、電解質、穩定劑、聚乙二醇、離散劑、防腐劑;第二試劑包含包被有抗人肌鈣蛋白I單克隆抗體的膠乳顆粒、緩衝液、表面活性劑、穩定劑、防腐劑。該申請的試劑盒顯示出更好的抗干擾能力。
2.該申請涉及一種肌酸激酶同工酶檢測試劑盒。該試劑盒包括第一試劑、第二試劑。第一試劑包含緩衝液、防腐劑、增凝劑、表面活性劑、保護劑、阻斷劑;第二試劑包含緩衝液、穩定劑、防腐劑、保護劑、聚苯乙烯膠乳顆粒、肌酸激酶同工酶抗體。該申請的試劑盒具有穩定性好、特異性強等優點,能夠應用於生化儀進行大批量的測定,能夠替代化學發光產品,降低醫院測定成本。
上述發明專利證書的取得不會對公司近期生產經營產生重大影響,但在一定程度上有利於發揮公司的知識產權優勢,促進技術創新,有利於提升公司的核心競爭力,有利於公司形成持續創新機制。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.